CD Capital

Neukio Biotherapeutics is an immune cell drug developer, focusing on the research and development and industrialization of immune cell drugs, developing iPSC-CAR-NK general-purpose spot immune cell products, and is committed to providing effective therapeutic drugs for cancer patients around the world.

Full-Life Technologies Limited is a global company specializing in RadioTherapeutics, with its headquarters in Shanghai, China, and operations extending to Europe. The firm focuses on targeted cancer therapy services within the radiotherapy field, aiming to enhance treatment outcomes for cancer patients. Full-Life is dedicated to advancing nuclear medicine through innovative research in radiopharmaceuticals, which supports healthcare providers in delivering effective cancer treatments.

Hui-Gene Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2018. The company specializes in the research and development of treatments for single-gene disorders and has also initiated projects targeting neurodegenerative diseases and vision disorders. By concentrating on these areas, Hui-Gene aims to advance therapeutic options for conditions often tied to genetic anomalies.

Reliable Med is a developer and provider of clinical mass spectrometry equipment designed for in vitro diagnostic (IVD) tests. The company focuses on addressing the needs of the medical industry by offering high-end clinical mass spectrometry devices and IVD detection kits. By doing so, Reliable Med aims to enhance the efficiency and accuracy of patient diagnoses within the healthcare sector.

Shandong Yingsheng Biotechnology Co., Ltd., established in 2009 and based in Jinan, China, specializes in the development and production of in vitro diagnostic reagents and medical equipment. The company focuses on molecular diagnostic techniques applicable to maternal and child health, neonatal genetic diseases, metabolic diseases, and birth defects. Yingsheng offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, 14 reagents for vitamin determination, and advanced detection systems such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry. These products facilitate early detection of genetic conditions and support disease prevention, contributing to improved human health outcomes.

Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

Developer of minimally invasive ventricular assist devices. The company's products with advantages of small trauma, large auxiliary flow, and easy to use, providing a circulation improvement plan that doctors can use conveniently and patients can afford.

Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in cell therapy, focusing on developing engineered Red Blood Cells (RBC) through its REDx platform. This innovative technology aims to treat a wide range of human diseases, including cancers, immunological and metabolic disorders, and rare diseases. By utilizing genetic engineering techniques on hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood, Westlake Therapeutics seeks to provide personalized and effective treatment options for patients, advancing the field of cellular medicine.

Reliable Med is a developer and provider of clinical mass spectrometry equipment designed for in vitro diagnostic (IVD) tests. The company focuses on addressing the needs of the medical industry by offering high-end clinical mass spectrometry devices and IVD detection kits. By doing so, Reliable Med aims to enhance the efficiency and accuracy of patient diagnoses within the healthcare sector.

SeekGene specializes in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. The company leverages its extensive research and clinical service experience to advance single-cell sequencing technology for real-world clinical research. SeekGene has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, and cost-effectiveness. This technology aims to facilitate the clinical transformation of single-cell sequencing, enabling better understanding of immune responses at the single-cell level. Additionally, SeekGene focuses on T cell receptor and peptide-bound major histocompatibility complex pairing technologies, which are essential for clinical and drug research, as well as for monitoring and treating various diseases.

Shandong Yingsheng Biotechnology Co., Ltd., established in 2009 and based in Jinan, China, specializes in the development and production of in vitro diagnostic reagents and medical equipment. The company focuses on molecular diagnostic techniques applicable to maternal and child health, neonatal genetic diseases, metabolic diseases, and birth defects. Yingsheng offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, 14 reagents for vitamin determination, and advanced detection systems such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry. These products facilitate early detection of genetic conditions and support disease prevention, contributing to improved human health outcomes.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

Hui-Gene Therapeutics Co., Ltd. is a biotechnology company based in Shanghai, China, founded in 2018. The company specializes in the research and development of treatments for single-gene disorders and has also initiated projects targeting neurodegenerative diseases and vision disorders. By concentrating on these areas, Hui-Gene aims to advance therapeutic options for conditions often tied to genetic anomalies.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

Xinzhi Medical is a Shanghai-based cardiovascular interventional therapy device developer.Xinzhi Medical is committed to promoting the technical innovation of cardiovascular interventional therapy and developing interventional non-implanted products in cardiovascular field continuously.

Guangdong Pulse Medical Technology Co., Ltd. is a manufacturer based in Zhuhai, China, specializing in the research, development, and sales of cardiovascular medical devices. Established in 2014, the company produces a range of products aimed at treating chronic cardiovascular diseases. Notable offerings include the left auricle occluder system, an external shock wave therapy system for the heart, and a device known as the Parachute, specifically designed for heart failure resulting from ischemic heart disease. Additionally, Pulse Medical develops wearable ECG monitoring equipment and cardiac imaging devices. The company benefits from governmental support and expert guidance, contributing to its advancements in the cardiovascular medical field.

Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.

Developer of molecular diagnostic technology designed to provide diagnostic instruments and detection reagents. The company focuses on research and development of molecular diagnostic technology and provides testing reagents for the diagnosis of severe diseases such as infectious diseases, enabling clients to improve diagnostic efficiency and reduce costs.

Researcher and developer of advanced genetic testing technology in the field of reproductive health. The company's technology focuses on the clinical application of cutting edge technologies in areas such as flow cytometry, and supporting reagents, non-invasive prenatal testing (NIPT), and tumor companion diagnosis through liquid biopsies, providing testing methods for various diseases.

Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, founded in 2014. The company specializes in developing innovative solutions for urology, particularly in the treatment of urethral blockages. Its flagship product, Optilume, is a drug-coated balloon catheter designed to treat urethral strictures in men. This device combines balloon dilation with localized drug delivery, utilizing the drug paclitaxel to inhibit cell proliferation and reduce the formation of scar tissue that can lead to stricture recurrence. By effectively covering the affected area during the procedure, Optilume offers a low-cost, minimally-invasive treatment option for patients suffering from urinary tract conditions, catering primarily to urologists and their patients.

Shenzhen Quiknos Network Technology Co., Ltd. is a healthcare company founded in 2015 and headquartered in Shenzhen, China. It operates a software application that integrates medical inspection and pharmaceutical distribution resources, focusing on enhancing healthcare delivery to primary medical institutions. Quiknos builds a mobile network and a professional cold chain logistics network that directly serves these institutions, enabling primary doctors in remote areas to offer high-quality medical diagnosis and treatment services comparable to those found in tertiary hospitals. The company's approach leverages advanced logistics and information technology to improve healthcare accessibility and efficiency.

A Biotech Company based In Ningbo.

CMAB BioPharm is a Biopharmaceutical Service Firm. Suqiao Bio is a flexible, comprehensive biopharmaceutical custom development and production (CDMO) service company. Strictly in compliance with the quality standards of domestic and international pharmaceutical production management regulations, Suqiao Bio is committed to providing Chinese and global customers with a one-stop shop for preclinical and clinical drug Phase I, Phase II, and Phase III biopharmaceutical products from DNA sequences to commercial production. solution.

12 Sigma Technologies, founded in April 2015, is a healthcare company that focuses on modern medical image diagnosis and data analysis. The firm leverages advanced artificial intelligence technologies to enhance medical imaging applications, believing in the significant potential of integrating AI with medical imaging. To further its mission, 12 Sigma has established partnerships with General Electric to co-develop innovative diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, the company collaborates with over 50 leading hospitals in China, engaging in applied medical diagnostics, technical research, and clinical trials to advance its healthcare solutions.

Shanghai Smartee Denti-Technology Co. Ltd is a company specializing in the development of an invisible orthodontic system, including a transparent aligner designed to move teeth into the desired position with precision. Founded in 2004 by a team of experts, including those with international experience and renowned orthodontics professionals, the company operates from the Shanghai Zhangjiang Hi-Tech Park. Smartee integrates advanced technologies such as 3D printing, computer-aided design (CAD), and digital modeling (CAM) to create aligners that are free from arch wires and brackets, making them safe for the oral cavity and easy to remove for eating and hygiene. The company collaborates with prominent research institutions, leveraging their expertise to enhance its digital orthodontic technology and has developed proprietary invisible appliance technology, which has received national accolades and patent protection for its innovative approach in orthodontics.

Kang Liming Bio is a biomedical technology company that specializes in the development, production and sales of tumor screening diagnostic products such as colorectal cancer fecal non-invasive screening kits.

Developer of detection reagents designed for gene testing. The company develops a capillary electrophoresis sequencing platform, a high throughput sequencing platform and a fluorescent quantitative detection platform to research and develop detection reagents, enabling clinical, forensic, biomedical and agricultural and animal husbandry institutions to have high quality gene testing products.

MicroTech Medical founded in January, 2011 in Hangzhou Future Technical City, which is the Industrial Garden for High-level Overseas Talents in Zhejiang Province, recieved capital from Eli Lilly and Company. They devote to innovate and manufacture high-tech and more affordable medical devices related to Diabetes Care.

Singlera Genomics Inc. specializes in developing genetic testing and molecular diagnostic technologies, particularly focusing on non-invasive methods. The company has created a methylation detection platform that enhances cancer screening for early tumor diagnosis and prevention. Its offerings include tumor diagnosis, personalized treatment options, non-invasive prenatal diagnosis, and pre-implantation genetic screening, along with customized scientific research services. With a commitment to precision medicine, Singlera Genomics aims to provide patients with early, accurate, and informative diagnoses. Founded in 2014, the company is headquartered in La Jolla, California, and operates research and development centers in Shanghai, China.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Shenzhen Quiknos Network Technology Co., Ltd. is a healthcare company founded in 2015 and headquartered in Shenzhen, China. It operates a software application that integrates medical inspection and pharmaceutical distribution resources, focusing on enhancing healthcare delivery to primary medical institutions. Quiknos builds a mobile network and a professional cold chain logistics network that directly serves these institutions, enabling primary doctors in remote areas to offer high-quality medical diagnosis and treatment services comparable to those found in tertiary hospitals. The company's approach leverages advanced logistics and information technology to improve healthcare accessibility and efficiency.

Percutek Therapeutics is a cardiovascular interventional device research and development manufacturer, mainly engaged in the research and development and production of cardiac and vascular related Class III minimally invasive interventional medical devices, dedicated to providing patients with safe interventional devices for cardiovascular clinical Medical solutions, etc.

Subo Medicine is a forensic and third-party medical testing service provider. Focus on providing users with judicial testing, medical testing and related services. It has four technology platforms: biochip technology platform, automated instrument technology platform, bioinformatics platform, genetic engineering technology platform, and based on professional identification methods and appraisal qualifications, it can also provide paternity test, forensic pathology identification and forensic clinical appraisal for users. And other business.

Righton is a Shanghai-based biotechnology company specializing in genetic engineering and the development of in vitro diagnostic products. The company focuses on researching and producing molecular diagnostic reagent kits, offering comprehensive scientific research and testing services. Righton aims to advance the field of molecular diagnostics through innovative solutions that enhance medical testing and diagnostics capabilities.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Med Lighter develops and offers a learning and communication platform for medical professionals. The company provides Med-lighter, an application that offers medical imaging information covering the head , neck , chest , abdomen, pelvis, limbs, and other body parts, with imaging modalities such as MRI, CT, X-ray, ultrasound, and other common ones, in addition to supplemental knowledge such as blood supply areas. Med Lighter was founded in 2014 and is based in the Beijing, China.

Biomarker Technologies Co., Ltd. offers gene sequencing and gene data mining services. It also offers scientific research, biocloud computing, and medical testing services. The company was founded in 2009 and is headquartered in Beijing, China.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.